|
-
andrepharma3
2025-3-14
-
109
0
|
|
-
andrepharma3
2025-3-14
-
108
0
|
|
-
andrepharma3
2025-3-14
-
96
0
|
|
-
andrepharma3
2025-3-14
-
107
0
|
|
-
andrepharma3
2025-3-14
-
111
0
|
|
-
andrepharma3
2025-3-14
-
111
0
|
|
-
andrepharma3
2025-3-14
-
108
0
|
|
-
andrepharma3
2025-3-14
-
120
0
|
|
-
andrepharma3
2025-3-14
-
105
0
|
|
-
andrepharma3
2025-3-14
-
109
0
|
|
-
andrepharma3
2025-3-14
-
111
0
|
|
-
andrepharma3
2025-3-14
-
98
0
|
|
-
andrepharma3
2025-3-14
-
98
0
|
|
-
andrepharma3
2025-3-14
-
122
0
|
|
-
andrepharma3
2025-3-14
-
101
0
|
|
-
andrepharma3
2025-3-14
-
109
0
|
|
-
andrepharma3
2025-3-14
-
111
0
|
|
-
andrepharma3
2025-3-14
-
131
0
|
|
-
andrepharma3
2025-3-14
-
96
0
|
|
-
andrepharma3
2025-3-14
-
98
0
|